These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15166968)

  • 1. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.
    Rosemurgy AS; Zervos EE; Clark WC; Thometz DP; Black TJ; Zwiebel BR; Kudryk BT; Grundy LS; Carey LC
    Ann Surg; 2004 Jun; 239(6):883-9; discussion 889-91. PubMed ID: 15166968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of refractory chylous ascites with peritoneovenous shunts.
    Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
    Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
    Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial.
    Fulenwider JT; Galambos JD; Smith RB; Henderson JM; Warren WD
    Arch Surg; 1986 Mar; 121(3):351-5. PubMed ID: 3947233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.
    White MA; Agle SC; Padia RK; Zervos EE
    Am Surg; 2011 Aug; 77(8):1070-5. PubMed ID: 21944526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW; Sood A; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term follow up after surgery for intractable ascites].
    Bancu L; Bara T; Jimboreanu O; Mureşan M; Bancu S
    Chirurgia (Bucur); 2009; 104(6):719-21. PubMed ID: 20187471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative treatment of malignant refractory ascites by positioning of Denver peritoneovenous shunt.
    Zanon C; Grosso M; Aprà F; Clara R; Bortolini M; Quaglino F; Cornaglia S; Simone P
    Tumori; 2002; 88(2):123-7. PubMed ID: 12088251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial.
    Rosemurgy AS; Serafini FM; Zweibel BR; Black TJ; Kudryk BT; Nord HJ; Goode SE
    J Gastrointest Surg; 2000; 4(6):589-97. PubMed ID: 11307093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneovenous shunting in intractable ascites.
    Deans GT; Spence RA; Johnston GW
    Ulster Med J; 1985 Oct; 54(2):155-9. PubMed ID: 4095803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
    Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.
    Rosemurgy AS; Frohman HA; Teta AF; Luberice K; Ross SB
    J Am Coll Surg; 2012 Apr; 214(4):445-53; discussion 453-5. PubMed ID: 22463885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.
    Deltenre P; Mathurin P; Dharancy S; Moreau R; Bulois P; Henrion J; Pruvot FR; Ernst O; Paris JC; Lebrec D
    Liver Int; 2005 Apr; 25(2):349-56. PubMed ID: 15780061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites.
    Williams DB; Waugh R; Selby W
    Aust N Z J Med; 1998 Oct; 28(5):620-6. PubMed ID: 9847951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.